Uptravi 16MCG NDC 66215-0616-06
Ended Awarded Last action
- Contract number
- 36C26022F0386
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $142,250
Award facts
- Contract value 100% obligated
- $142,249.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Titusville, Hopewell Township, NJ 08560, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$29,169 | |
| Supplemental Agreement for work within scope | $3,595 | |
| Original award | $167,823 |
About this award
This is a Delivery Order awarded by the Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products specializing in treatments for pulmonary arterial hypertension and other rare diseases. The contract is for the supply of Uptravi 16MCG (Selexipag) under Actelion's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a ceiling value of $142,249.86 and a period of performance ending on July 12, 2023. This order is not a small business set-aside. Actelion holds several significant Indefinite Delivery Vehicles (IDVs) with the VA, including a $105 million, five-year FSS contract and multiple Blanket Purchase Agreements (BPAs) valued at $60 million and $83.5 million, which facilitate the procurement of Actelion's specialized pulmonary arterial hypertension medications for VA medical centers and other federal healthcare facilities.
Quick answers
Who was awarded contract 36C26022F0386?
36C26022F0386 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on July 13, 2022.
How much is contract 36C26022F0386 worth?
The government has obligated $142,250 on 36C26022F0386.
Is contract 36C26022F0386 an order under another contract?
Yes. 36C26022F0386 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26022F0386 competed?
The extent of competition for 36C26022F0386 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award